Who are Amnio-Maxx® Dual Layer Amnion Patch's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): dHACM (AmnioWrap), Micronized dHACM.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/amnio-maxx-dual-layer-amnion-patch.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Amnio-Maxx® Dual Layer Amnion Patch — Competitive Intelligence Brief

Amnio-Maxx® Dual Layer Amnion Patch (Amnio-Maxx® Dual Layer Amnion Patch) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biologic tissue graft. Area: Other.

marketed Biologic tissue graft Wound healing and tissue regeneration Other Biologic Live · refreshed every 30 min

Target snapshot

Amnio-Maxx® Dual Layer Amnion Patch (Amnio-Maxx® Dual Layer Amnion Patch) — Royal Biologics.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Amnio-Maxx® Dual Layer Amnion Patch TARGET	Amnio-Maxx® Dual Layer Amnion Patch	Royal Biologics	marketed	Biologic tissue graft	Wound healing and tissue regeneration
dHACM (AmnioWrap)	dHACM (AmnioWrap)	Louisiana State University Health Sciences Center in New Orleans	marketed	Biologic tissue graft / Wound care product
Micronized dHACM	Micronized dHACM	MiMedx Group, Inc.	phase 3	Biologic tissue graft / Regenerative medicine product

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biologic tissue graft class)

Royal Biologics · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Amnio-Maxx® Dual Layer Amnion Patch — Competitive Intelligence Brief. https://druglandscape.com/ci/amnio-maxx-dual-layer-amnion-patch. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab